Vergote, I., Mirza, M., Sehouli, J., Lorusso, D., Kose, F., Cibula, D., Westermann, A., Collins, D., Banerjee, S., Oaknin, A., Soumaoro, I., Jain, S., & Monk, B. J. (n.d.). 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. International journal of gynecological cancer, 32, A64. http://access.bl.uk/ark:/81055/vdc_100168339637.0x00004a